The synthetic metalloproteinase inhibitor batimastat suppresses injury-induced phosphorylation of MAP kinase ERK1/ERK2 and phenotypic modification of arterial smooth muscle cells in vitro (Q73061972)
Jump to navigation
Jump to search
scientific article published on 01 September 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The synthetic metalloproteinase inhibitor batimastat suppresses injury-induced phosphorylation of MAP kinase ERK1/ERK2 and phenotypic modification of arterial smooth muscle cells in vitro |
scientific article published on 01 September 2000 |
Statements
The synthetic metalloproteinase inhibitor batimastat suppresses injury-induced phosphorylation of MAP kinase ERK1/ERK2 and phenotypic modification of arterial smooth muscle cells in vitro (English)
C Lövdahl
J Thyberg
A Hultgârdh-Nilsson
1 September 2000